The upcoming Telangana’s flagship biotech event, BioAsia 2025, is set to provide a global platform for innovation and entrepreneurship and showcase start-ups as catalysts of change.
The Innovation Zone at BioAsia will have a start-up pavilion and an incubator pavilion and a select group of about 80 start-ups will showcase their innovative solutions that have potential to transform healthcare globally.
BioAsia, to be held between February 25-26, has attracted interest from both national and international corporations medical technology start-ups revolutionising Drug Discovery Platforms to medical device start-ups solving for cancer screening, nasal septum, limb movements etc., Additionally, biotechnology start-ups are making strides in areas such as small molecule nanoparticles and novel drug candidates.
“Bio Asia is rightly poised as a global platform fostering innovation and collaboration within the life sciences and healthcare sectors. It is a great booster to the start-up ecosystem, with promising ventures showcasing their solutions to a global audience,’‘ D Sridhar Babu, Minister for Industries and IT E&C Government of Telangana said in a release.
Jayesh Ranjan, Special Chief Secretary said, “The Life sciences space in Telangana has grown at a rapid pace and we are experiencing a massive interest in the opportunities prevalent in the State. To fuel this momentum, Bio Asia 2025 has enabled an Incubator Pavilion and Innovation Zone which will aim at fostering innovation and business growth for start-ups who are creating revolutionary solutions in healthcare and life sciences.”
According to Shakthi Nagappan, CEO, Telangana Life Sciences, BioAsia 2025 with the theme Catalysts of Change will offer an unparalleled opportunity to forge partnerships and drive impactful collaborations in an ever-evolving environment.
